BMY.US and Bain Capital Establish New Biopharmaceutical Company to Develop Therapies for Autoimmune Diseases
CNS Finance APP has learned that BMY.US (Bristol Myers Squibb) and Bain Capital have jointly announced the establishment of a new, independent biopharmaceutical company focused on developing therapies